Others

Genlink Pharma Solutions Pvt Ltd - Compliances-Reg. 52 (7) - Statement of Material Deviations in proceeds of issue of NCD / NCRP

| Updated on May 20, 2019 Published on May 20, 2019

For the half year ended 31st March, 2019 there is no material deviation in the use of proceeds of Secured Redeemable Non-Convertible Debentures from the objects stated in the offer document.

Pdf Link: Genlink Pharma Solutions Pvt Ltd - Compliances-Reg. 52 (7) - Statement of Material Deviations in proceeds of issue of NCD / NCRP

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on May 20, 2019
This article is closed for comments.
Please Email the Editor